The Ulcerative colitis - ustekinumab as a new biologic therapy, review 2024

• Главные авторы: Zuzanna Felińska (Автор), Julia Silldorff (Автор), Tomasz Fura (Автор), Marcin Dudek (Автор), Radosław Zaucha (Автор), Oliwia Iszczuk (Автор), Stanisław Anczyk (Автор), Magdalena Gajkiewicz (Автор), Małgorzata Zając (Автор)
• Формат: ‌
• Опубликовано: Nicolaus Copernicus University in Toruń, 2024-08-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Biologic agents have significantly transformed the therapeutic approach to ulcerative colitis. Anti-tumor necrosis factor (TNF) agents were the pioneering biologic drugs introduced to induce and maintain remission in this inflammatory bowel disease. Recently, ustekinumab, another biologic option, ha...